Tina Ambani inaugurates Kokilaben Dhirubhai Ambani Hospital in Indore

KDAH Indore is a super-speciality, patient-centric, tertiary-care institution located in the Nipaniya area of Indore.

ERES IV acquires a majority stake in Oncodesign Services

Oncodesign Services (ODS ), with 600 clients in 33 countries and 227 employees worldwide, provides services from target identification to hit-to-lead and lead optimization through to IND filing.

USFDA approves Imjudo in combination with Imfinzi for liver cancer

Approval based on HIMALAYA Phase III trial results which showed single priming dose of Imjudo added to Imfinzi reduced risk of death by 22% vs. sorafenib

Merck and the Bill & Melinda Gates Medical Research Institute announce licensing agreement for tuberculosis antibiotic candidates

The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.

WHO, FAO, UNEP and WOAH launch One Health Joint Plan of Action

This first joint plan on One Health aims to create a framework to integrate systems and capacity so that we can collectively better prevent, predict, detect, and respond to health threats

Evonik and Phathom Pharmaceuticals partner to produce novel acid-blocker vonoprazan

Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)

WEF recognises Dr. Reddy’s Hyderabad factory as part of its Global Lighthouse Network

Dr. Reddy’s largest manufacturing facility in Bachupally, Hyderabad, joins Global Lighthouse Network of the World Economic Forum

PM Modi dedicates to the nation various healthcare facilities in Civil Hospital Asarwa, Ahmedabad

Prime Minister said that it is a huge day for health in Gujarat and congratulated everyone associated with these projects for completing them on time.

Panacea Biotec bags US $127.30 mn for supply of Pentavalent Vaccine

UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027

Piramal Pharma appoints Vibha Paul Rishi as Non- Executive Director